A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

On The Readout LOUD podcast, STAT reporters talked with BIO's CEO John Crowley about RFK Jr. and tariffs, and discussed calls ...

The pharmaceutical and healthcare sectors were previously viewed as a relative safe haven from the tariff-induced market turmoil. The Health Care Select Sector SPDR exchange-traded fund XLV fell 7.8% ...

KalVista Pharmaceuticals has licensed commercialisation rights for sebetralstat, an oral on-demand treatment for hereditary ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Immunovant Inc. is accused of discriminatory hiring due to the use of artificial intelligence in the hiring process. But one ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

The shares of Fabtech Technologies began trading on the BSE SME platform at a significant premium of 90% prior to two months ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has dipped by 11.85%, which has investors questioning if this is right ...